Founded in 2007, Biophore has established itself as a trusted partner for niche and complex products. With 4 US FDA and EU approved API manufacturing facilities, one dedicated intermediate facility and a world class R&D lab housing 400 scientists with varied expertise, Biophore has emerged as one of the leading API companies globally. We have consistently been in the Top 10 US DMF filers with the US FDA over the past 5 years and with most of our APIs, we are one of the fastest companies to bring them to the market enabling wider access for patients worldwide
These are entries in government registers. BharatSeal has not checked them separately.
Record completeness: 5 of 7 records on file
Not on record: GST registration, Income-tax PAN
7 facts · 0 checked · 5 on record or declared · 2 unknown
Checks confirm records. They do not prove quality or delivery.
API development and manufacturing partner
Hyderabad, TG, India
No. Biophore India Pharmaceuticals Private Limited has not claimed its BharatSeal profile. Registry records on this page are on record in government registers; BharatSeal has not checked them separately.
Biophore India Pharmaceuticals Private Limited was incorporated in 2007 per Ministry of Corporate Affairs records under CIN U24232TG2007PTC053381. The company has been operating for 19 years, with the registration auditable on mca.gov.in.
Biophore India Pharmaceuticals Private Limited's current directors include Dr. Jagadeesh Babu Rangisetty, Ph.D., Dr. Manik Reddy Pullagurla, Ph.D., Injectable APIs, and 1 other. Director records are sourced from the MCA21 corporate registry and reflect the latest filing with the Ministry of Corporate Affairs.
Send an enquiry through BharatSeal. Every enquiry is logged so you have a record of the conversation.
Matched on what they make. Nearest first when the match is as close.